Federated Hermes, Inc. Corbus Pharmaceuticals Holdings, Inc. Transaction History

Federated Hermes, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.21 - $0.53 $326 - $823	-1,553 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$0.32 - $0.67 $66 - $140	-209 Reduced 11.86%	1,553 $1,000
Q3 2021 Nov 15, 2021	BUY	$1.01 - $1.82 $1,779 - $3,206	1,762 New	1,762 $2,000
Q3 2019 Nov 14, 2019	SELL	$4.87 - $7.08 $574 - $835	-118 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$6.6 - $7.8 $4,554 - $5,382	-690 Reduced 85.4%	118 $1,000
Q1 2019 May 10, 2019	BUY	$5.76 - $8.95 $4,654 - $7,231	808 New	808 $6,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.